GLPwatch
Trials (2081)
Page 18 of 35.
- Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
- Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
- Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
- Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
- Brain Activation and Satiety in Children 2
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
- Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
- Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
- Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects
- Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
- A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
- Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
- Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
- A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
- A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools
- A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
- Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
- DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
- Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
- Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
- Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity Patients
- Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
- A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
- Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
- Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
- Exenatide for Smoking Cessation and Prevention of Weight Gain
- RISE Adult Medication Study
- Effects of GLP-1 on Chronic Heart Failure
- Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways)
- Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes
- Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
- Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
- A Study With NLY01 in Subjects With Type 2 Diabetes
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
- Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
- A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
- The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
- Tirzepatide to Slow Biological Aging
- GLP-1/Basal Insulin Combination Therapy
- A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
- Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes
- Protein Supplementation Intervention on Body Weight
- Effect of LIXIsenatide on the Renal System
- A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
- Tirzepatide Use in People With Obesity and Type 1 Diabetes
- Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
- Reward Mechanisms in Obesity
- Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
- Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin